The action of antithrombin III on plasmin and activators of plasminogen. - Suppr | 超能文献

The action of antithrombin III on plasmin and activators of plasminogen.

作者信息

Crawford G P, Ogston D

出版信息

Biochim Biophys Acta. 1975 May 23;391(1):189-92. doi: 10.1016/0005-2744(75)90165-5.

DOI:10.1016/0005-2744(75)90165-5

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

The action of antithrombin III on plasmin and activators of plasminogen.

Biochim Biophys Acta. 1975 May 23;391(1):189-92. doi: 10.1016/0005-2744(75)90165-5.

2

Interaction of heparin with plasminogen activators and plasminogen: effects on the activation of plasminogen.肝素与纤溶酶原激活剂及纤溶酶原的相互作用：对纤溶酶原激活的影响。

Biochemistry. 1986 Jul 15;25(14):4033-40. doi: 10.1021/bi00362a007.

3

Activation of human Glu-plasminogen to Glu-plasmin by urokinase in presence of plasmin inhibitors. Streptomyces leupeptin and human plasma alpha1-antitrypsin and antithrombin III (plus heparin).

J Biol Chem. 1977 Jun 10;252(11):3945-51.

4

Tissue plasminogen activator and urokinase mediate the binding of Glu-plasminogen to plasma fibrin I. Evidence for new binding sites in plasmin-degraded fibrin I.组织型纤溶酶原激活物和尿激酶介导谷氨酸纤溶酶原与血浆纤维蛋白I的结合。纤溶酶降解的纤维蛋白I中存在新结合位点的证据。

J Biol Chem. 1985 Apr 10;260(7):4432-40.

5

Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.由尿激酶或组织型纤溶酶原激活剂激活的血浆中纤溶酶原和纤溶酶抑制剂复合物分子形式的形成顺序。

Biochem J. 1984 Oct 1;223(1):179-87. doi: 10.1042/bj2230179.

6

Properties of three different molecular forms of the alpha 2 plasmin inhibitor.α2纤溶酶抑制剂三种不同分子形式的特性

Eur J Biochem. 1981 Nov;120(1):105-12. doi: 10.1111/j.1432-1033.1981.tb05675.x.

7

Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.尿激酶在人血浆中产生的纤溶酶原和纤溶酶的不同分子形式及其与蛋白酶抑制剂以及纤维蛋白原和纤维蛋白溶解的关系。

Biochem J. 1974 Nov;143(2):273-83. doi: 10.1042/bj1430273.

8

Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis.从人血浆中分离和鉴定α2-纤溶酶抑制剂。一种抑制激活剂诱导的血凝块溶解的新型蛋白酶抑制剂。

J Biol Chem. 1976 Oct 10;251(19):5956-65.

9

The inhibition of human plasmin by human antithrombin-heparin cofactor.人抗凝血酶-肝素辅因子对人纤溶酶的抑制作用。

J Biol Chem. 1974 Jul 25;249(14):4335-8.

10

Conversion of Glu-plasminogen to plasmin by urokinase in the presence of tranexamic acid.在氨甲环酸存在的情况下，尿激酶将谷氨酸纤溶酶原转化为纤溶酶。

Thromb Res. 1981 May 15;22(4):437-43. doi: 10.1016/0049-3848(81)90105-5.

引用本文的文献

1

Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection.静脉血栓形成的流行病学、病理生理学以及严重急性呼吸综合征冠状病毒 2 感染的抗凝治疗和试验。

J Vasc Surg Venous Lymphat Disord. 2021 Jan;9(1):23-35. doi: 10.1016/j.jvsv.2020.08.030. Epub 2020 Sep 8.

2

The anticoagulant activity of dermatan sulphates: evidence against the involvement of antithrombin III.硫酸皮肤素的抗凝活性：反对抗凝血酶III参与的证据。

Br J Pharmacol. 1981 Jan;72(1):81-8. doi: 10.1111/j.1476-5381.1981.tb09108.x.

3

The primary inhibitor of plasmin in human plasma.人血浆中纤溶酶的主要抑制剂。

Biochem J. 1976 Dec 1;159(3):545-53. doi: 10.1042/bj1590545.